Difference between revisions of "Disseminated oligodendroglial-like leptomeningeal tumour"

From Libre Pathology
Jump to navigation Jump to search
(→‎Images: added)
(Update -> Change in name)
Line 1: Line 1:
'''Disseminated oligodendroglial-like leptomeningeal tumour''' (abbreviated DOLN) is a [[neuropathology tumour]] related to [[pilocytic astrocytoma]]. It is currently not listed in the WHO classification of CNS tumours.
'''Diffuse leptomeningeal glioneuronal tumour''' (abbreviated DLGNT) is a [[neuropathology tumour]] related to [[pilocytic astrocytoma]]. The future WHO classification of CNS tumours will include it as separate entity.


==General==
==General==
Features:
Features:
*Currently no WHO grade assigned.
*Currently no WHO grade assigned.
* Previously known as '''Disseminated oligodendroglial-like leptomeningeal tumour''' (abbreviated DOLN)
*Low-grade lesion but anaplastic progression reported.
*Low-grade lesion but anaplastic progression reported.
*AKA "diffuse leptomeningeal glioneural tumor" or "disseminated oligodendroglial-like leptomeningeal tumor of childhood" (DOGLT).<ref>{{Cite journal  | last1 = Preuss | first1 = M. | last2 = Christiansen | first2 = H. | last3 = Merkenschlager | first3 = A. | last4 = Hirsch | first4 = FW. | last5 = Kiess | first5 = W. | last6 = Müller | first6 = W. | last7 = Kästner | first7 = S. | last8 = Henssler | first8 = A. | last9 = Pekrun | first9 = A. | title = Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity [corrected]. | journal = J Neurooncol | volume = 124 | issue = 1 | pages = 65-74 | month = Aug | year = 2015 | doi = 10.1007/s11060-015-1735-z | PMID = 25672644 }}</ref>
*AKA "diffuse leptomeningeal glioneural tumor" or "disseminated oligodendroglial-like leptomeningeal tumor of childhood" (DOGLT).<ref>{{Cite journal  | last1 = Preuss | first1 = M. | last2 = Christiansen | first2 = H. | last3 = Merkenschlager | first3 = A. | last4 = Hirsch | first4 = FW. | last5 = Kiess | first5 = W. | last6 = Müller | first6 = W. | last7 = Kästner | first7 = S. | last8 = Henssler | first8 = A. | last9 = Pekrun | first9 = A. | title = Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity [corrected]. | journal = J Neurooncol | volume = 124 | issue = 1 | pages = 65-74 | month = Aug | year = 2015 | doi = 10.1007/s11060-015-1735-z | PMID = 25672644 }}</ref>
Line 21: Line 22:
* [[Oligodendroglioma]]-like cells with low-mitotic activity.
* [[Oligodendroglioma]]-like cells with low-mitotic activity.
* Rare ganglion/ganglioid cells.
* Rare ganglion/ganglioid cells.
* Ocassionally eosinophilic granular bodies and Rosenthal fibers.
* Infiltrative growth pattern.
* Infiltrative growth pattern.
* Variable mitotic activity.
* Variable mitotic activity.

Revision as of 10:14, 12 November 2020

Diffuse leptomeningeal glioneuronal tumour (abbreviated DLGNT) is a neuropathology tumour related to pilocytic astrocytoma. The future WHO classification of CNS tumours will include it as separate entity.

General

Features:

  • Currently no WHO grade assigned.
  • Previously known as Disseminated oligodendroglial-like leptomeningeal tumour (abbreviated DOLN)
  • Low-grade lesion but anaplastic progression reported.
  • AKA "diffuse leptomeningeal glioneural tumor" or "disseminated oligodendroglial-like leptomeningeal tumor of childhood" (DOGLT).[1]
  • Intermediate prognosis.


Gross

Features:

  • No solid tumour.
  • Diffuse leptomeningeal expansion.
    • Hydrocaphalus due to CSF occlusion.
    • May spread extraneural through shunts. [2]
    • Rarely Cysts.[3]

Microscopic

Features:

  • Oligodendroglioma-like cells with low-mitotic activity.
  • Rare ganglion/ganglioid cells.
  • Ocassionally eosinophilic granular bodies and Rosenthal fibers.
  • Infiltrative growth pattern.
  • Variable mitotic activity.

IHC

Fetaures:[4][5]

  • OLIG2 (7 of 9) (78 %).
  • S100 (11 of 12) (92 %).
  • GFAP (12 of 31) (39 %).
  • Synaptophysin (19 of 27) (70 %).
  • NeuN -ve.
  • EMA -ve.
  • IDH-1 -ve.
  • HuC/D +/-ve.
  • CD99 -ve.

Molecular

  • 1p loss (or 1p/19q loss)[6]
  • KIAA1549-BRAF fusions.[8]
    • High frequency of co-occurence of BRAF-KIAA1549 fusions and 1p deletion.
    • BRAF-KIAA1549 fusions are usu. absent in oligodendroglioma.[9]
  • BRAF V600E-negative.

Images

  • Radiopedia.org [[1]]

DDx

See also

References

  1. Preuss, M.; Christiansen, H.; Merkenschlager, A.; Hirsch, FW.; Kiess, W.; Müller, W.; Kästner, S.; Henssler, A. et al. (Aug 2015). "Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity [corrected].". J Neurooncol 124 (1): 65-74. doi:10.1007/s11060-015-1735-z. PMID 25672644.
  2. Kessler, BA.; Bookhout, C.; Jaikumar, S.; Hipps, J.; Lee, YZ.. "Disseminated oligodendroglial-like leptomeningeal tumor with anaplastic progression and presumed extraneural disease: case report.". Clin Imaging 39 (2): 300-4. doi:10.1016/j.clinimag.2014.11.018. PMID 25518979.
  3. Acar, NP.; Oguz, KK.; Kurne, AT.; Nurlu, G.; Ozer, H.; Soylemezoglu, F. (Mar 2015). "Disseminated cystic lesions: a case of disseminated oligodendroglial-like leptomeningeal tumor.". Neurology 84 (13): 1382-3. doi:10.1212/WNL.0000000000001410. PMID 25825464.
  4. Rodriguez, FJ.; Perry, A.; Rosenblum, MK.; Krawitz, S.; Cohen, KJ.; Lin, D.; Mosier, S.; Lin, MT. et al. (Nov 2012). "Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity.". Acta Neuropathol 124 (5): 627-41. doi:10.1007/s00401-012-1037-x. PMID 22941225.
  5. Preuss, M.; Christiansen, H.; Merkenschlager, A.; Hirsch, FW.; Kiess, W.; Müller, W.; Kästner, S.; Henssler, A. et al. (Aug 2015). "Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity [corrected].". J Neurooncol 124 (1): 65-74. doi:10.1007/s11060-015-1735-z. PMID 25672644.
  6. Bourne, TD.; Mandell, JW.; Matsumoto, JA.; Jane, JA.; Lopes, MB. (Dec 2006). "Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. Case report.". J Neurosurg 105 (6 Suppl): 465-9. doi:10.3171/ped.2006.105.6.465. PMID 17184079.
  7. Preuss, M.; Christiansen, H.; Merkenschlager, A.; Hirsch, FW.; Kiess, W.; Müller, W.; Kästner, S.; Henssler, A. et al. (Aug 2015). "Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity [corrected].". J Neurooncol 124 (1): 65-74. doi:10.1007/s11060-015-1735-z. PMID 25672644.
  8. Rodriguez, FJ.; Schniederjan, MJ.; Nicolaides, T.; Tihan, T.; Burger, PC.; Perry, A. (Apr 2015). "High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN).". Acta Neuropathol 129 (4): 609-10. doi:10.1007/s00401-015-1400-9. PMID 25720745.
  9. Gierke, M.; Sperveslage, J.; Schwab, D.; Beschorner, R.; Ebinger, M.; Schuhmann, MU.; Schittenhelm, J. (Jun 2015). "Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.". J Cancer Res Clin Oncol. doi:10.1007/s00432-015-2006-2. PMID 26115961.
  10. Bourne, TD.; Mandell, JW.; Matsumoto, JA.; Jane, JA.; Lopes, MB. (Dec 2006). "Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. Case report.". J Neurosurg 105 (6 Suppl): 465-9. doi:10.3171/ped.2006.105.6.465. PMID 17184079.